| Frontier Home Health And Hospice | |
| 907 N Poplar Street, Suite 277, Casper, Wyoming 82601 | |
| (307) 234-6684 | |
| Name | Frontier Home Health And Hospice |
|---|---|
| Location | 907 N Poplar Street, Suite 277, Casper, Wyoming |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 537044 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 82601, 82602, 82604, 82605, 82609, 82620, 82633, 82636, 82637, 82644 |
| NPI Number | 1093315350 |
| Organization Name | LHCG CLXXIII LLC |
| Address | 907 N Poplar St Ste 277, Casper, WY 82601 |
| Phone Number | 307-234-6684 |
News Archive
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Final first-in-man (FIM) clinical results on the use of the FlexStent® Femoropopliteal SE Stent System were presented recently at the VIVA conference in Las Vegas by Dr. Andrew Holden of Auckland City Hospital. The clinical results originated from Flexible Stenting Solutions, Inc.'s (FSS) FIM study conducted in New Zealand by Principle Investigator Dr. Andrew Holden, and FSS's supplementary study conducted in Germany by Principle Investigator Dr. Dierk Scheinert of University of Leipzig - Heart Center.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital are looking for adults and children to participate in three studies that will help them better understand how the flu vaccine works in people of different ages.
The British Mycological Society, in association with Elsevier, the world-leading publisher of scientific, technical and medical information, today announced the final programme for the 9th Mycological Congress IMC9: The Biology of Fungi. This congress takes place every 4 years at a different venue around the world.
› Verified 4 days ago
| NPI Number | 1255524674 |
| Organization Name | FRONTIER WYOMING, L.L.C. |
| Doing Business As | FRONTIER HOME HEALTH AND HOSPICE |
| Address | 907 N Poplar St, Suite 277, Casper, WY 82601 |
| Phone Number | 307-234-6684 |
News Archive
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Final first-in-man (FIM) clinical results on the use of the FlexStent® Femoropopliteal SE Stent System were presented recently at the VIVA conference in Las Vegas by Dr. Andrew Holden of Auckland City Hospital. The clinical results originated from Flexible Stenting Solutions, Inc.'s (FSS) FIM study conducted in New Zealand by Principle Investigator Dr. Andrew Holden, and FSS's supplementary study conducted in Germany by Principle Investigator Dr. Dierk Scheinert of University of Leipzig - Heart Center.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital are looking for adults and children to participate in three studies that will help them better understand how the flu vaccine works in people of different ages.
The British Mycological Society, in association with Elsevier, the world-leading publisher of scientific, technical and medical information, today announced the final programme for the 9th Mycological Congress IMC9: The Biology of Fungi. This congress takes place every 4 years at a different venue around the world.
› Verified 4 days ago
| NPI Number | 1619560471 |
| Organization Name | EH HEALTH HOME HEALTH OF THE NORTHWEST, LLC |
| Doing Business As | ENHABIT HOME HEALTH |
| Address | 907 N Poplar St Ste 277, Casper, WY 82601 |
| Phone Number | 307-234-6684 |
News Archive
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Final first-in-man (FIM) clinical results on the use of the FlexStent® Femoropopliteal SE Stent System were presented recently at the VIVA conference in Las Vegas by Dr. Andrew Holden of Auckland City Hospital. The clinical results originated from Flexible Stenting Solutions, Inc.'s (FSS) FIM study conducted in New Zealand by Principle Investigator Dr. Andrew Holden, and FSS's supplementary study conducted in Germany by Principle Investigator Dr. Dierk Scheinert of University of Leipzig - Heart Center.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital are looking for adults and children to participate in three studies that will help them better understand how the flu vaccine works in people of different ages.
The British Mycological Society, in association with Elsevier, the world-leading publisher of scientific, technical and medical information, today announced the final programme for the 9th Mycological Congress IMC9: The Biology of Fungi. This congress takes place every 4 years at a different venue around the world.
› Verified 4 days ago
| NPI Number | 1790385086 |
| Organization Name | LHCG CLXXIV LLC |
| Doing Business As | FRONTIER HOSPICE |
| Address | 907 N Poplar St Ste 277, Casper, WY 82601 |
| Phone Number | 307-234-6684 |
News Archive
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Final first-in-man (FIM) clinical results on the use of the FlexStent® Femoropopliteal SE Stent System were presented recently at the VIVA conference in Las Vegas by Dr. Andrew Holden of Auckland City Hospital. The clinical results originated from Flexible Stenting Solutions, Inc.'s (FSS) FIM study conducted in New Zealand by Principle Investigator Dr. Andrew Holden, and FSS's supplementary study conducted in Germany by Principle Investigator Dr. Dierk Scheinert of University of Leipzig - Heart Center.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital are looking for adults and children to participate in three studies that will help them better understand how the flu vaccine works in people of different ages.
The British Mycological Society, in association with Elsevier, the world-leading publisher of scientific, technical and medical information, today announced the final programme for the 9th Mycological Congress IMC9: The Biology of Fungi. This congress takes place every 4 years at a different venue around the world.
› Verified 4 days ago
| NPI Number | 1932174398 |
| Organization Name | INTEGRICARE, INC |
| Doing Business As | NORTH PLATTE HOME HEALTH AND HOSPICE |
| Address | 130 N Ash St, Professional Plaza Suite 201, Casper, WY 82601 |
| Phone Number | 307-234-6684 |
News Archive
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Final first-in-man (FIM) clinical results on the use of the FlexStent® Femoropopliteal SE Stent System were presented recently at the VIVA conference in Las Vegas by Dr. Andrew Holden of Auckland City Hospital. The clinical results originated from Flexible Stenting Solutions, Inc.'s (FSS) FIM study conducted in New Zealand by Principle Investigator Dr. Andrew Holden, and FSS's supplementary study conducted in Germany by Principle Investigator Dr. Dierk Scheinert of University of Leipzig - Heart Center.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital are looking for adults and children to participate in three studies that will help them better understand how the flu vaccine works in people of different ages.
The British Mycological Society, in association with Elsevier, the world-leading publisher of scientific, technical and medical information, today announced the final programme for the 9th Mycological Congress IMC9: The Biology of Fungi. This congress takes place every 4 years at a different venue around the world.
› Verified 4 days ago
| Quality Rating: |
News Archive
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Final first-in-man (FIM) clinical results on the use of the FlexStent® Femoropopliteal SE Stent System were presented recently at the VIVA conference in Las Vegas by Dr. Andrew Holden of Auckland City Hospital. The clinical results originated from Flexible Stenting Solutions, Inc.'s (FSS) FIM study conducted in New Zealand by Principle Investigator Dr. Andrew Holden, and FSS's supplementary study conducted in Germany by Principle Investigator Dr. Dierk Scheinert of University of Leipzig - Heart Center.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital are looking for adults and children to participate in three studies that will help them better understand how the flu vaccine works in people of different ages.
The British Mycological Society, in association with Elsevier, the world-leading publisher of scientific, technical and medical information, today announced the final programme for the 9th Mycological Congress IMC9: The Biology of Fungi. This congress takes place every 4 years at a different venue around the world.
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 85.8 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 96.9 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.4 | 99.6 |
| How often the home health team checked patients for depression | 88.8 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 76.6 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 81.5 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 86.4 | 96.4 |
News Archive
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Final first-in-man (FIM) clinical results on the use of the FlexStent® Femoropopliteal SE Stent System were presented recently at the VIVA conference in Las Vegas by Dr. Andrew Holden of Auckland City Hospital. The clinical results originated from Flexible Stenting Solutions, Inc.'s (FSS) FIM study conducted in New Zealand by Principle Investigator Dr. Andrew Holden, and FSS's supplementary study conducted in Germany by Principle Investigator Dr. Dierk Scheinert of University of Leipzig - Heart Center.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital are looking for adults and children to participate in three studies that will help them better understand how the flu vaccine works in people of different ages.
The British Mycological Society, in association with Elsevier, the world-leading publisher of scientific, technical and medical information, today announced the final programme for the 9th Mycological Congress IMC9: The Biology of Fungi. This congress takes place every 4 years at a different venue around the world.
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 71.3 | 79.6 |
| How often patients got better at getting in and out of bed | 81.6 | 81.1 |
| How often patients got better at bathing | 79.5 | 82.3 |
| How often patients’ breathing improved | 72.3 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 56.6 | 75 |
| How often home health patients had to be admitted to the hospital | 12 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 22.2 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 93.6 | 94 |
News Archive
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Final first-in-man (FIM) clinical results on the use of the FlexStent® Femoropopliteal SE Stent System were presented recently at the VIVA conference in Las Vegas by Dr. Andrew Holden of Auckland City Hospital. The clinical results originated from Flexible Stenting Solutions, Inc.'s (FSS) FIM study conducted in New Zealand by Principle Investigator Dr. Andrew Holden, and FSS's supplementary study conducted in Germany by Principle Investigator Dr. Dierk Scheinert of University of Leipzig - Heart Center.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital are looking for adults and children to participate in three studies that will help them better understand how the flu vaccine works in people of different ages.
The British Mycological Society, in association with Elsevier, the world-leading publisher of scientific, technical and medical information, today announced the final programme for the 9th Mycological Congress IMC9: The Biology of Fungi. This congress takes place every 4 years at a different venue around the world.
› Verified 4 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Final first-in-man (FIM) clinical results on the use of the FlexStent® Femoropopliteal SE Stent System were presented recently at the VIVA conference in Las Vegas by Dr. Andrew Holden of Auckland City Hospital. The clinical results originated from Flexible Stenting Solutions, Inc.'s (FSS) FIM study conducted in New Zealand by Principle Investigator Dr. Andrew Holden, and FSS's supplementary study conducted in Germany by Principle Investigator Dr. Dierk Scheinert of University of Leipzig - Heart Center.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital are looking for adults and children to participate in three studies that will help them better understand how the flu vaccine works in people of different ages.
The British Mycological Society, in association with Elsevier, the world-leading publisher of scientific, technical and medical information, today announced the final programme for the 9th Mycological Congress IMC9: The Biology of Fungi. This congress takes place every 4 years at a different venue around the world.
› Verified 4 days ago
The patient survey data of Frontier Home Health And Hospice is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 87 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 84 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 77 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 77 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 78 | 78 |
News Archive
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Final first-in-man (FIM) clinical results on the use of the FlexStent® Femoropopliteal SE Stent System were presented recently at the VIVA conference in Las Vegas by Dr. Andrew Holden of Auckland City Hospital. The clinical results originated from Flexible Stenting Solutions, Inc.'s (FSS) FIM study conducted in New Zealand by Principle Investigator Dr. Andrew Holden, and FSS's supplementary study conducted in Germany by Principle Investigator Dr. Dierk Scheinert of University of Leipzig - Heart Center.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital are looking for adults and children to participate in three studies that will help them better understand how the flu vaccine works in people of different ages.
The British Mycological Society, in association with Elsevier, the world-leading publisher of scientific, technical and medical information, today announced the final programme for the 9th Mycological Congress IMC9: The Biology of Fungi. This congress takes place every 4 years at a different venue around the world.
› Verified 4 days ago
Frontier Home Health And Hospice Location: 907 N Poplar Street, Suite 277, Casper, Wyoming 82601 Ratings: Phone: (307) 234-6684 | |
All About Family Inc Location: 195 Pronghorn St, Casper, Wyoming 82601 Ratings: NA Phone: (307) 232-6459 | |
Epsilon Health Solutions Llc Location: 145 S Durbin St, Suite 105, Casper, Wyoming 82601 Ratings: Phone: (307) 333-4574 | |
Casper Home Health Llc Location: 3211 Energy Lane Suite 310, Casper, Wyoming 82604 Ratings: Phone: (307) 439-4110 |